Skip to main content

Peer Review reports

From: Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns

Original Submission
14 Apr 2015 Submitted Original manuscript
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
17 Dec 2015 Editorially accepted
16 Jan 2016 Article published 10.1186/s12885-015-2029-8

You can find further information about peer review here.

Back to article page